Edition:
United Kingdom

People: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

732.00GBp
14 Jun 2019
Change (% chg)

-11.00 (-1.48%)
Prev Close
743.00
Open
729.00
Day's High
747.00
Day's Low
720.00
Volume
71,285
Avg. Vol
73,464
52-wk High
1,064.38
52-wk Low
575.32

Diggle, Martin 

Mr. Martin Diggle serves as Non-Executive Director of Oxford BioMedica PLC. Mr Diggle is a founder of Vulpes Investment Management, a Cayman Fund Manager which currently manages five funds including the Vulpes Life Sciences Fund which is the Group’s second largest shareholder. An investment professional with 30 years experience in investment banking and fund management, Mr Diggle has extensive, first-hand knowledge of the global financial markets and is an expert in emerging markets and Russia, in particular, where he was a partner and director of UBS Brunswick between 1994 and 2003. He has been an investor in life sciences and biotechnology since 1999 and has developed a passionate interest in the sector having worked closely with several companies as a stakeholder over the past decade. Mr Diggle holds a master’s degree in Philosophy, Politics and Economics from University of Oxford, and he is a non-Executive Director of Proteome Sciences plc and Chronos Therapeutics.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --